What Washington’s Nuclear Gamble with Saudi Means 
Carey Gillam on the Supreme Court’s Decision in the Roundup Case 
US Makes Belated Leap Into Naval Drone Warfare 
By: Tomoaki Takei
Multinational pharma giant Eli Lilly’s Mounjaro (tirzepatide), the dual GIP/GLP-1 receptor agonist, is at the center of a rapidly escalating public health storm in East Asia. While clinically approved as a life-saving treatment for Type 2 diabetes, the drug has been effectively deified on social media as the ultimate cosmetic weight-los…
Don't Miss:
-
What Washington’s Nuclear Gamble with Saudi Means
-
Carey Gillam on the Supreme Court’s Decision in the Roundup Case
-
US Makes Belated Leap Into Naval Drone Warfare
-
Inside the Matrix: How models, influencers and engagement quotas power the Social Discovery Group’s dating machine and global profits
-
Why Lower Oil Prices Don’t Bring Cheaper Gasoline